Nelly Mauras, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    NovoNordisk
    Topic: 
    Investigator initiated research study on GH impact on skeletal muscle
    Date added: 
    10/07/2023
    Mitigation strategy: 
    Recusal
    Date reviewed: 
    04/19/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    NovoNordisk
    Topic: 
    Use of Somapacitan in patients born SGA, Idiopathic short stature, Turner Syndrome, Noonan Syndrome
    Date added: 
    10/07/2023
    Mitigation strategy: 
    Recusal
    Date reviewed: 
    04/19/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Dexcom
    Topic: 
    Investigator initiated study on Disparities on use of advanced diabetes technologies in children
    Date added: 
    10/07/2023
    Mitigation strategy: 
    Recusal
    Date reviewed: 
    04/19/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Pfizer
    Topic: 
    Use of long-acting GH in children with GH deficiency
    Date added: 
    10/07/2023
    Mitigation strategy: 
    Recusal
    Date reviewed: 
    04/19/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Agios
    Topic: 
    Nemours approved consultancy Re: aromatase blockage, an expected side effect in children with a rare hemolytic anemia
    Date added: 
    10/07/2023
    Mitigation strategy: 
    Recusal
    Date reviewed: 
    04/19/2024
Return to 3rd Annual Nemours Children's Health Research Week